Your browser doesn't support javascript.
loading
Metadata for Data dIscoverability aNd Study rEplicability in obseRVAtional Studies (MINERVA): Development and Pilot of a Metadata List and Catalogue in Europe.
Pajouheshnia, Romin; Gini, Rosa; Gutierrez, Lia; Swertz, Morris A; Hyde, Eleanor; Sturkenboom, Miriam; Arana, Alejandro; Franzoni, Carla; Ehrenstein, Vera; Roberto, Giuseppe; Gil, Miguel; Maciá, Miguel Angel; Schäfer, Wiebke; Haug, Ulrike; Thurin, Nicolas H; Lassalle, Régis; Droz-Perroteau, Cécile; Zaccagnino, Silvia; Busto, Maria Paula; Middelkoop, Bas; Gembert, Karin; Sanchez-Saez, Francisco; Rodriguez-Bernal, Clara; Sanfélix-Gimeno, Gabriel; Hurtado, Isabel; Acosta, Manuel Barreiro-de; Poblador-Plou, Beatriz; Carmona-Pírez, Jonás; Gimeno-Miguel, Antonio; Prados-Torres, Alexandra; Schultze, Anna; Jansen, Ella; Herings, Ron; Kuiper, Josine; Locatelli, Igor; Jazbar, Janja; Zerovnik, Spela; Kos, Mitja; Smit, Steven; Lind, Sirje; Metspalu, Andres; Simou, Stefania; Hedenmalm, Karin; Cochino, Ana; Alcini, Paolo; Kurz, Xavier; Perez-Gutthann, Susana.
Afiliação
  • Pajouheshnia R; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands.
  • Gini R; Department of Epidemiology, RTI Health Solutions, Barcelona, Spain.
  • Gutierrez L; Agenzia Regionale di Sanità della Toscana, Florence, Italy.
  • Swertz MA; Department of Epidemiology, RTI Health Solutions, Barcelona, Spain.
  • Hyde E; Department of Genetics, University Medical Centre Groningen, Groningen, The Netherlands.
  • Sturkenboom M; Department of Genetics, University Medical Centre Groningen, Groningen, The Netherlands.
  • Arana A; University Medical Centre Utrecht, Utrecht, The Netherlands.
  • Franzoni C; Department of Epidemiology, RTI Health Solutions, Barcelona, Spain.
  • Ehrenstein V; Department of Epidemiology, RTI Health Solutions, Barcelona, Spain.
  • Roberto G; Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark.
  • Gil M; Agenzia Regionale di Sanità della Toscana, Florence, Italy.
  • Maciá MA; Base de datos para la Investigación Farmacoepidemiológica en Atención Primaria, Agencia Española de Medicamentos y Productos Sanitarios, Madrid, Spain.
  • Schäfer W; Base de datos para la Investigación Farmacoepidemiológica en Atención Primaria, Agencia Española de Medicamentos y Productos Sanitarios, Madrid, Spain.
  • Haug U; Leibniz Institute for Prevention Research and Epidemiology, Bremen, Germany.
  • Thurin NH; Leibniz Institute for Prevention Research and Epidemiology, Bremen, Germany.
  • Lassalle R; Faculty of Human and Health Science, University of Bremen, Bremen, Germany.
  • Droz-Perroteau C; Bordeaux PharmacoEpi, INSERM CIC-P 1401, Université de Bordeaux, Bordeaux, France.
  • Zaccagnino S; Bordeaux PharmacoEpi, INSERM CIC-P 1401, Université de Bordeaux, Bordeaux, France.
  • Busto MP; Bordeaux PharmacoEpi, INSERM CIC-P 1401, Université de Bordeaux, Bordeaux, France.
  • Middelkoop B; European Society for Blood & Marrow Transplantation, Leiden, The Netherlands.
  • Gembert K; European Society for Blood & Marrow Transplantation, Leiden, The Netherlands.
  • Sanchez-Saez F; European Society for Blood & Marrow Transplantation, Leiden, The Netherlands.
  • Rodriguez-Bernal C; Department of Epidemiology, Karolinska Institutet, Stockholm, Sweden.
  • Sanfélix-Gimeno G; Foundation for the Promotion of Health and Biomedical Research of the Valencia Region, Valencia, Spain.
  • Hurtado I; Foundation for the Promotion of Health and Biomedical Research of the Valencia Region, Valencia, Spain.
  • Acosta MB; Foundation for the Promotion of Health and Biomedical Research of the Valencia Region, Valencia, Spain.
  • Poblador-Plou B; Foundation for the Promotion of Health and Biomedical Research of the Valencia Region, Valencia, Spain.
  • Carmona-Pírez J; Spanish Working Group on Crohn's Disease and Ulcerative Colitis, Bilbao, Spain.
  • Gimeno-Miguel A; EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, Miguel Servet University Hospital, Zaragoza, Spain.
  • Prados-Torres A; EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, Miguel Servet University Hospital, Zaragoza, Spain.
  • Schultze A; Technical Advisory Subdirectorate of Information Management (STAGI), Andalusian Health Service (SAS), Seville, Spain.
  • Jansen E; EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, Miguel Servet University Hospital, Zaragoza, Spain.
  • Herings R; EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, Miguel Servet University Hospital, Zaragoza, Spain.
  • Kuiper J; London School of Hygiene and Tropical Medicine, London, UK.
  • Locatelli I; PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands.
  • Jazbar J; PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands.
  • Zerovnik S; PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands.
  • Kos M; Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia.
  • Smit S; Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia.
  • Lind S; Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia.
  • Metspalu A; Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia.
  • Simou S; Institute of Genomics, University of Tartu, Tartu, Estonia.
  • Hedenmalm K; Institute of Genomics, University of Tartu, Tartu, Estonia.
  • Cochino A; Institute of Genomics, University of Tartu, Tartu, Estonia.
  • Alcini P; European Medicines Agency, Amsterdam, The Netherlands.
  • Kurz X; European Medicines Agency, Amsterdam, The Netherlands.
  • Perez-Gutthann S; European Medicines Agency, Amsterdam, The Netherlands.
Pharmacoepidemiol Drug Saf ; 33(8): e5871, 2024 Aug.
Article em En | MEDLINE | ID: mdl-39145406
ABSTRACT

PURPOSE:

Metadata for data dIscoverability aNd study rEplicability in obseRVAtional studies (MINERVA), a European Medicines Agency-funded project (EUPAS39322), defined a set of metadata to describe real-world data sources (RWDSs) and piloted metadata collection in a prototype catalogue to assist investigators from data source discoverability through study conduct.

METHODS:

A list of metadata was created from a review of existing metadata catalogues and recommendations, structured interviews, a stakeholder survey, and a technical workshop. The prototype was designed to comply with the FAIR principles (findable, accessible, interoperable, reusable), using MOLGENIS software. Metadata collection was piloted by 15 data access partners (DAPs) from across Europe.

RESULTS:

A total of 442 metadata variables were defined in six domains institutions (organizations connected to a data source); data banks (data collections sustained by an organization); data sources (collections of linkable data banks covering a common underlying population); studies; networks (of institutions); and common data models (CDMs). A total of 26 institutions were recorded in the prototype. Each DAP populated the metadata of one data source and its selected data banks. The number of data banks varied by data source; the most common data banks were hospital administrative records and pharmacy dispensation records (10 data sources each). Quantitative metadata were successfully extracted from three data sources conforming to different CDMs and entered into the prototype.

CONCLUSIONS:

A metadata list was finalized, a prototype was successfully populated, and a good practice guide was developed. Setting up and maintaining a metadata catalogue on RWDSs will require substantial effort to support discoverability of data sources and reproducibility of studies in Europe.
Assuntos
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Estudos Observacionais como Assunto / Metadados Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Pharmacoepidemiol Drug Saf Assunto da revista: EPIDEMIOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Estudos Observacionais como Assunto / Metadados Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Pharmacoepidemiol Drug Saf Assunto da revista: EPIDEMIOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Holanda